Sort
51,593 grants matching “hepatitis”
HIV Infection in Drug Users in Two International Sites
$538,442Sherwood L Gorbach · Tufts University Boston · R01 · FY2008 · DA
Targeted chemotherapy delivery and capture
$538,425Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2020 · EB
Liver Parametric PET
$538,373Guobao Wang · University Of California At Davis · R01 · FY2022 · DK
Role of liver fat and fibrosis in human CVD risk phenotypes.
$538,353Rohit Loomba · University Of California, San Diego · P01 · FY2023 · HL
HCV TRANSMISSION: SEX, VIOLENCE ALCOHOL &DRUG USE
$538,310Pacific Institute For Res And Evaluation · R01 · FY2000 · DA
The role of HCV RNA-targeted phosphatase PTPRE in T cell activation
$538,304Jack T Stapleton · University Of Iowa · R56 · FY2017 · AI
Mechanisms of antibody-mediated control of repeated hepatitis C virus infection in humans
$538,301Justin Richard Bailey · Johns Hopkins University · U19 · FY2024 · AI
Clinical Core
$538,189Richard Douglas Moore · Johns Hopkins University · P30 · FY2019 · AI
Non Alcoholic Steatohepatitis Clinical Research Network
$538,178Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · DK
CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv
$538,135Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2015 · CA
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins
$538,135Alan Richard Tall · Columbia University Health Sciences · P01 · FY2017 · HL
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins
$538,135Alan Richard Tall · Columbia University Health Sciences · P01 · FY2016 · HL
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
$538,134Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DK
Role of Forkhead proteins in insulin action
$538,099Domenico Accili · Columbia University Health Sciences · R01 · FY2024 · DK
Research Initiative for Scientific Enhancement at CSULB
$538,076Marco Antonio Lopez · California State University Long Beach · R25 · FY2007 · GM
Regulation of Drug Metabolizing Enzyme Ontogeny
$538,055Ronald N Hines · Medical College Of Wisconsin · R01 · FY2011 · GM
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$538,034Patrice Mimche · University Of Utah · R01 · FY2024 · DK
Alpha and Beta Cell Function in Normal and Diabetic Man
$537,960John E Gerich · University Of Rochester · R01 · FY2007 · DK
Hostility, Race, and Glucose Metabolism
$537,942Duke University · R01 · FY2004 · HL
Adiponectin, A Protein Secreted From Adipose Tissue
$537,920Philipp E Scherer · Ut Southwestern Medical Center · R01 · FY2023 · DK
Adiponectin, A Protein Secreted From Adipose Tissue
$537,920Philipp E Scherer · Ut Southwestern Medical Center · R01 · FY2022 · DK
Adiponectin, A Protein Secreted From Adipose Tissue
$537,920Philipp E Scherer · Ut Southwestern Medical Center · R01 · FY2021 · DK
Understanding human neutralizing antibodies to hepatitis C virus
$537,865Mansun Law · Scripps Research Institute, The · R01 · FY2013 · AI
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$537,842Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2023 · DK
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)
$537,839Hilary A. Tindle · Vanderbilt University Medical Center · K12 · FY2025 · DA